AstraZeneca Pharma India Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	1,157	1,615	992.9	616	933
Depreciation & Amortization	385.4	148.1	162.6	169.5	197.5
Other Amortization	14.5	1.3	-	-	-
Loss (Gain) From Sale of Assets	-3.2	-0.3	-24.9	-28.2	-21.7
Asset Writedown & Restructuring Costs	4.6	12.4	-	-	3.8
Stock-Based Compensation	51.4	27.4	23.7	18.2	14.8
Provision & Write-off of Bad Debts	6.6	54.4	17	42.9	27.2
Other Operating Activities	69.1	-298	-286.5	-139.3	-67.3
Change in Accounts Receivable	-316.8	-511.8	-231.7	-49	-45.8
Change in Inventory	-3,206	-376.7	-499.9	195.8	53.5
Change in Accounts Payable	2,598	-313.7	374.4	120.5	-313.4
Change in Other Net Operating Assets	-107.3	-79.5	55.3	61.6	266.2
Operating Cash Flow	653.6	278.7	582.9	1,008	1,048
Operating Cash Flow Growth	134.52%	-52.19%	-42.17%	-3.80%	19.86%
Capital Expenditures	-17.5	-107.6	-85.2	-96.2	-77.1
Sale of Property, Plant & Equipment	7.1	4.1	34.8	32.5	24.2
Investment in Securities	-	-	-	-	1,690
Other Investing Activities	318.4	320.9	231.5	111.1	93.2
Investing Cash Flow	308	217.4	181.1	47.4	1,730
Long-Term Debt Repaid	-41.3	-38.6	-38.5	-35.1	-28.8
Total Debt Repaid	-41.3	-38.6	-38.5	-35.1	-28.8
Net Debt Issued (Repaid)	-41.3	-38.6	-38.5	-35.1	-28.8
Common Dividends Paid	-600	-400	-200	-50	-50
Other Financing Activities	-14.6	-5.2	-6.3	-9.5	-10.9
Financing Cash Flow	-655.9	-443.8	-244.8	-94.6	-89.7
Net Cash Flow	305.7	52.3	519.2	960.8	2,688
Free Cash Flow	636.1	171.1	497.7	911.8	970.7
Free Cash Flow Growth	271.77%	-65.62%	-45.42%	-6.07%	32.61%
Free Cash Flow Margin	3.71%	1.32%	4.96%	11.32%	11.93%
Free Cash Flow Per Share	25.44	6.84	19.91	36.47	38.83
Cash Interest Paid	14.6	5.2	6.3	9.5	10.9
Cash Income Tax Paid	641.9	564.3	408.2	247.9	325.6
Levered Free Cash Flow	1,391	-37.96	762.44	901.26	841.91
Unlevered Free Cash Flow	1,400	-30.46	766.38	907.2	848.73
Change in Working Capital	-1,032	-1,282	-301.9	328.9	-39.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.